Clinical Trial Update: Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

View source ↗

Summary

A completed real-world study evaluating Inclisiran in Chinese adults with primary hypercholesterolemia or mixed dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia | Status: COMPLETED